These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3098958)

  • 21. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatographic analysis of docusate sodium in soft gelatin capsules.
    Hogue DR; Zimmardi JA; Shah KA
    J Pharm Sci; 1992 Apr; 81(4):359-61. PubMed ID: 1380076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. VI. Preparation and evaluation of ibuprofen soft gelatin capsule.
    Takahashi M; Yuasa H; Kanaya Y; Uchiyama M
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1398-401. PubMed ID: 7553987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution testing of soft shell capsules-acetaminophen and nifedipine.
    Bottom CB; Clark M; Carstensen JT
    J Pharm Sci; 1997 Sep; 86(9):1057-61. PubMed ID: 9294822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of gastric ulcer with enprostil.
    Navert H
    Am J Med; 1986 Aug; 81(2A):75-9. PubMed ID: 3092660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stomach ulcer healing with enprostil, an orally effective prostaglandin E2 analog: direct comparative study with ranitidine].
    Hüttemann W; Beckenbach HP; Daake H; Dammann HG; Jancke T; Kalek HD; Kühn V; Martens W; Müller P; Rohner HG
    Z Gastroenterol; 1986 May; 24(5):252-6. PubMed ID: 3088859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion.
    Waterbury LD; Mahoney JM; Peak TM; Cohn RG; Garay GL
    Am J Med; 1986 Aug; 81(2A):30-3. PubMed ID: 3092651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
    Wan B; Zordan CA; Lu X; McGeorge G
    AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ultraviolet and liquid chromatographic methods for dissolution testing of sodium phenytoin capsules.
    Shah VP; Ogger KE
    J Pharm Sci; 1986 Nov; 75(11):1113-5. PubMed ID: 3820108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enprostil in the acute treatment of duodenal ulcer: direct comparative study with pirenzepin].
    Rohner HG; Beckenbach HP; Daake H; Dammann HG; Hüttemann R; Kalek S; Kühn V; Müller P; Simon B
    Z Gastroenterol; 1986 May; 24(5):257-61. PubMed ID: 3088860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data.
    Donato EM; Martins LA; Fröehlich PE; Bergold AM
    J Pharm Biomed Anal; 2008 Jul; 47(3):547-52. PubMed ID: 18403160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic fate of the new anti-ulcer drug enprostil in animals. 1st communication: absorption, distribution and excretion in the mouse, rat and rabbit.
    Smith S; Teitelbaum P; Bowen L; Tomlinson R; Berry P; Yani A; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):335-41. PubMed ID: 2502986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.